AAAAAA
Results: 51-75/167
Authors:
TOOKE JE
SHORE AC
COHEN RA
KLUFT C
Citation: Je. Tooke et al., DIABETIC ANGIOPATHY - TRACKING DOWN THE CULPRITS, Journal of diabetes and its complications, 10(3), 1996, pp. 173-181
Authors:
BLOEMENKAMP K
HELMERHORST F
JESPERSEN J
KLUFT C
SKOUBY S
HANNAFORD P
NORRIS L
ARCHER D
LIDEGAARD O
LUBSEN K
ROSENDAAL F
THOROGOOD M
VANDENBROUCKE J
BACK D
BRAKMAN O
FOTHERBY K
LEUVEN JG
HAMERLYNCK J
KUHL H
SAMSIOE G
Citation: K. Bloemenkamp et al., CONSENSUS DEVELOPMENT MEETING 1995 - COMBINED ORAL-CONTRACEPTIVES ANDCARDIOVASCULAR-DISEASE - THE CONSENSUS STATEMENT ISSUED AFTER THE 2NDEUROPEAN CONFERENCE ON SEX STEROIDS AND METABOLISM, AMSTERDAM, NOVEMBER 1995, Gynecological endocrinology, 10(1), 1996, pp. 1-5
Authors:
HEEREMANS JLM
MIJNHEER FW
GERRITSEN HR
PREVOST R
KLUFT C
CROMMELIN DJA
Citation: Jlm. Heeremans et al., LONG-TERM STABILITY OF LIPOSOMES CONTAINING BOTH TISSUE-TYPE PLASMINOGEN-ACTIVATOR AND GLU-PLASMINOGEN, International journal of pharmaceutics, 129(1-2), 1996, pp. 191-202
Authors:
MENNEN LI
SCHOUTEN EG
GROBBEE DE
KLUFT C
Citation: Li. Mennen et al., COAGULATION-FACTOR-VII, DIETARY-FAT AND BLOOD-LIPIDS - A REVIEW, Thrombosis and haemostasis, 76(4), 1996, pp. 492-499
Authors:
DEMAAT MPM
ARNOLD AER
VANBUUREN S
WILSON JHP
KLUFT C
Citation: Mpm. Demaat et al., MODULATION OF PLASMA-FIBRINOGEN LEVELS BY TICLOPIDINE IN HEALTHY-VOLUNTEERS AND PATIENTS WITH STABLE ANGINA-PECTORIS, Thrombosis and haemostasis, 76(2), 1996, pp. 166-170
Authors:
HEEREMANS JLM
LOS P
PREVOST R
CROMMELIN DJA
KLUFT C
Citation: Jlm. Heeremans et al., FIBRIN BINDING OF PLASMINOGEN COATED LIPOSOMES IN-VITRO, Thrombosis and haemostasis, 75(1), 1996, pp. 134-139
Authors:
MYRUP B
ROSSING P
JENSEN T
GRAM J
KLUFT C
JESPERSEN J
Citation: B. Myrup et al., FIBRINOLYSIS IN INSULIN-DEPENDENT DIABETIC-PATIENTS WITH AND WITHOUT NEPHROPATHY, Fibrinolysis, 10(5-6), 1996, pp. 331-335
Authors:
WIERIK EJMVT
KLUFT C
VANDENBERG H
WESTSTRATE JA
Citation: Ejmvt. Wierik et al., CONSUMPTION OF REDUCED-FAT PRODUCTS, HEMOSTATIC PARAMETERS AND ORAL GLUCOSE-TOLERANCE TEST, Fibrinolysis, 10(3), 1996, pp. 159-166
Authors:
SLAGBOOM PE
KLUFT C
Citation: Pe. Slagboom et C. Kluft, GENETIC-STUDIES OF COMPLEX DISEASES - GIANT STEPS FROM PROMISE TO PROOF, Fibrinolysis, 10, 1996, pp. 1-2
Authors:
KORTMANN CBHMJ
KLUFT C
VERHEIJEN JH
Citation: Cbhmj. Kortmann et al., PREFACE, Fibrinolysis, 10, 1996, pp. 1-1
Authors:
VANDERBOM JG
BOTS ML
HAVERKATE F
GROBBEE DE
KLUFT C
Citation: Jg. Vanderbom et al., FIBRINOLYTIC CAPACITY AND RISK OF MYOCARDIAL-INFARCTION, Fibrinolysis, 10, 1996, pp. 9-12
Authors:
IACOVIELLO L
DICASTELNUOVO A
DEKNIJFF P
DORAZIO A
AMORE C
KLUFT C
DONATI MB
Citation: L. Iacoviello et al., ALU REPEAT POLYMORPHISM IN THE TISSUE-TYPE PLASMINOGEN-ACTIVATOR (T-PA) GENE, T-PA LEVELS AND RISK OF FAMILIAL MYOCARDIAL-INFARCTION (MI), Fibrinolysis, 10, 1996, pp. 13-16
Authors:
HEIJMANS BT
KLUFT C
BOTS ML
LAGAAY AM
BRAND A
GROBBEE DE
KNOOK DL
SLAGBOOM PE
Citation: Bt. Heijmans et al., STUDY DESIGN FOR THE IDENTIFICATION OF LOCI AFFECTING HUMAN LONGEVITY, Fibrinolysis, 10, 1996, pp. 19-20
Authors:
SPANNAGL M
HENSELMANN P
WEBER M
GRAM J
JESPERSEN J
KLUFT C
Citation: M. Spannagl et al., FACTOR-XII DEPENDENT FIBRINOLYTIC-ACTIVITY IS DECREASED IN THE ACUTE-PHASE OF MYOCARDIAL OR CEREBRAL INFARCTION, Fibrinolysis, 10, 1996, pp. 51-52
Authors:
LEEBEEK FWG
LOS P
KLUFT C
Citation: Fwg. Leebeek et al., A MONOCLONAL-ANTIBODY AGAINST THE COOH-TERMINAL SITE OF ALPHA(2)-ANTIPLASMIN REVEALS HETEROGENEITY IN THE NONPLASMINOGEN BINDING FORM OF ALPHA(2)-ANTIPLASMIN, Fibrinolysis, 10, 1996, pp. 67-70
Authors:
GRAM J
JESPERSEN J
KLUFT C
DECLERCK P
Citation: J. Gram et al., VARIOUS APPROACHES TO STANDARDIZATION AND THE IMPORTANCE OF MEASUREMENT ACCURACY, Fibrinolysis, 10, 1996, pp. 113-116
Authors:
MEIJER P
KLUFT C
Citation: P. Meijer et C. Kluft, CRITERIA FOR A SPECIFIC PLASMIN INHIBITION TEST (SPIT) IN HUMAN PLASMA, Fibrinolysis, 10, 1996, pp. 121-123
Authors:
HUISMAN LGM
VANGRIENSVEN JMT
KLUFT C
Citation: Lgm. Huisman et al., USEFULNESS AND LIMITATIONS OF ACTILYSE(R) FOR STANDARDIZATION OF TISSUE-TYPE PLASMINOGEN-ACTIVATOR (T-PA) ASSAYS IN BLOOD, Fibrinolysis, 10, 1996, pp. 125-127
Authors:
HENNIS BC
HOFFMANN JJML
KLUFT C
Citation: Bc. Hennis et al., THE RADIAL IMMUNODIFFUSION ASSAY FOR PLASMA HISTIDINE-RICH GLYCOPROTEIN (HRG) BASED ON A POLYCLONAL ANTIBODY, SHOWS A DIFFERENT SPECIFICITYTOWARDS THE 2 VARIANTS OF A COMMON AMINO-ACID POLYMORPHISM, Fibrinolysis, 10, 1996, pp. 133-134
Authors:
BIASUCCI LM
DEMAAT MPM
MEO A
VANDERGREEF W
SUMMARIA F
QUARANTA G
LIUZZO G
KLUFT C
MASERI A
Citation: Lm. Biasucci et al., ANALYSIS OF ACTIVATION MARKERS OF COAGULATION, FIBRINOLYSIS AND INFLAMMATION IN UNSTABLE ANGINA BY PROBIT TRANSFORMATION, Fibrinolysis, 10, 1996, pp. 145-147
Authors:
MEIJER P
VANDERHAM F
KLUFT C
Citation: P. Meijer et al., THE USE OF STABILYTE(R) PLASMA MAY CAUSE CHANGES IN PH IN THE ASSAY OF SOME FIBRINOLYSIS ANALYTES AND MIGHT EFFECT RESULTS, Fibrinolysis, 10, 1996, pp. 155-157
Authors:
ANDREOTTI F
PREVOST R
LUPI A
HAMILTON J
DEBART ACW
HUISMAN LGM
MASERI A
KLUFT C
Citation: F. Andreotti et al., CIRCADIAN PATTERNS OF PLASMA T-PA AND PAI-1 ANTIGEN LEVELS IN PATIENTS WITH SEVERE PERIPHERAL ATHEROSCLEROSIS, Fibrinolysis, 10, 1996, pp. 159-160
Authors:
BOTS ML
VANDERBOM JG
HAVERKATE F
MEIJER P
HOFMAN A
GROBBEE DE
KLUFT C
Citation: Ml. Bots et al., ACTIVATED PROTEIN-C RESPONSE AND CARDIOVASCULAR RISK-FACTORS IN THE ELDERLY - THE ROTTERDAM STUDY, Fibrinolysis, 10, 1996, pp. 161-164
Authors:
CLASON SB
MEIJER P
KLUFT C
ERSDAL E
Citation: Sb. Clason et al., A NOVEL METHOD, COAMATIC(R) PLASMIN INHIBITOR, FOR THE SPECIFIC DETERMINATION OF PLASMIN INHIBITOR ACTIVITY IN PLASMA, Fibrinolysis, 10, 1996, pp. 165-167
Authors:
KLUFT C
MEIJER P
Citation: C. Kluft et P. Meijer, UPDATE 1996 - BLOOD COLLECTION AND HANDLING PROCEDURES FOR ASSESSMENTOF PLASMINOGEN ACTIVATORS AND INHIBITORS (LEIDEN FIBRINOLYSIS WORKSHOP), Fibrinolysis, 10, 1996, pp. 171-179